• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C3肾炎因子(C3NeF):液相和细胞结合的替代途径转化酶的稳定作用。

C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase.

作者信息

Daha M R, Fearon D T, Austen K F

出版信息

J Immunol. 1976 Jan;116(1):1-7.

PMID:1245733
Abstract

C3 nephritic factor (C3NeF) defined by the capacity of nephritic serum and its fractions to initiate loss of the B antigen of C3 in normal serum was purified from the serum of three different donors and shown to function by stabilization of membrane-bound and fluid phase alternative pathway C3 convertase. C3NeF converts cell-bound C3B sites in a dose-related manner to CEB(NeF) sites, which exhibit an approximate 10-fold increase in half-life. The linear relationship between the C3NeF input and the residual hemolytic sites on EAC43B present after incubation for 20 min at 30 degrees C, during which labile C3B sites have decayed, indicates that the number of residual C3B sites is directly related to the dose of C3NeF. The capacity of C3NeF to stabilize the C3B convertase in a temperature- and dose-dependent manner, which is independent of binding or consumption of C3NeF, in a fluid phase reaction mixture of 125I-B, 131I-C3 and D permits isolation of a 10S complex containing radiolabeled C3 and B and exhibiting C3, convertase activity on an exogenous C3 source. Thus, the stabilizing effect of C3NeF is not limited to membrane-bound C3B but is also sufficient to permit recovery of a fluid phase C3 convertase formed during the interaction of C3, B, and D.

摘要

通过肾炎血清及其组分引发正常血清中C3的B抗原丢失的能力所定义的C3肾炎因子(C3NeF),从三名不同供体的血清中纯化得到,并显示其通过稳定膜结合和液相替代途径C3转化酶发挥作用。C3NeF以剂量相关的方式将细胞结合的C3B位点转化为CEB(NeF)位点,其半衰期增加约10倍。在30℃孵育20分钟后,不稳定的C3B位点已经衰变,此时C3NeF输入与EAC43B上残留溶血位点之间的线性关系表明,残留C3B位点的数量与C3NeF的剂量直接相关。在125I-B、131I-C3和D的液相反应混合物中,C3NeF以温度和剂量依赖的方式稳定C3B转化酶的能力,这与C3NeF的结合或消耗无关,允许分离出一种含有放射性标记C3和B的10S复合物,并对外源C3来源表现出C3转化酶活性。因此,C3NeF的稳定作用不仅限于膜结合的C3B,也足以使在C3、B和D相互作用过程中形成的液相C3转化酶得以恢复。

相似文献

1
C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase.C3肾炎因子(C3NeF):液相和细胞结合的替代途径转化酶的稳定作用。
J Immunol. 1976 Jan;116(1):1-7.
2
Formation in the presence of C3 nephritic factor (C3NeF) of an alternative pathway C3 convertase containing uncleaved B.在C3肾炎因子(C3NeF)存在的情况下,形成含有未裂解B的替代途径C3转化酶。
Immunology. 1976 Nov;31(5):789-96.
3
Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.膜增生性肾小球肾炎和同种异体移植排斥反应中补体激活途径。
Transplant Proc. 1977 Mar;9(1):729-39.
4
C3 requirements for formation of alternative pathway C5 convertase.形成替代途径C5转化酶所需的C3。
J Immunol. 1976 Aug;117(2):630-4.
5
Production of nephritic factor of the alternative complement pathway by Epstein Barr virus-transformed B cell lines derived from a patient with membranoproliferative glomerulonephritis.源自一名膜增生性肾小球肾炎患者的爱泼斯坦-巴尔病毒转化B细胞系产生替代补体途径的肾炎因子。
J Immunol. 1986 Jun 15;136(12):4451-5.
6
C3 nephritic factor (C3NeF): dissociation of cell-bound and fluid phase stabilization of alternative pathway C3 convertase.C3肾炎因子(C3NeF):细胞结合型与液相替代途径C3转化酶稳定性的解离
Clin Exp Immunol. 1986 Aug;65(2):450-7.
7
Activation of the classical pathway of complement by the C3NeF-stabilized cell-bound amplification convertase.C3NeF稳定的细胞结合放大转化酶对补体经典途径的激活。
J Immunol. 1979 Mar;122(3):801-5.
8
Complement activation by heat-killed human kidney cells: formation, activity, and stabilization of cell-bound C3 convertases.热灭活人肾细胞激活补体:细胞结合C3转化酶的形成、活性及稳定性
J Immunol. 1984 Aug;133(2):877-81.
9
Further evidence for the antibody nature of C3 nephritic factor (C3NeF).C3 肾炎因子(C3NeF)抗体性质的进一步证据。
J Immunol. 1979 Aug;123(2):755-8.
10
Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis.C3肾炎因子在膜增生性肾小球肾炎中的生物学意义。
Clin Nephrol. 1982 Nov;18(5):240-6.

引用本文的文献

1
Acquired drivers of C3 glomerulopathy.C3肾小球病的后天性驱动因素。
Clin Kidney J. 2025 Jan 27;18(3):sfaf022. doi: 10.1093/ckj/sfaf022. eCollection 2025 Mar.
2
The ouroboros of autoimmunity.自身免疫的衔尾蛇。
Nat Immunol. 2024 May;25(5):743-754. doi: 10.1038/s41590-024-01815-y. Epub 2024 May 2.
3
Defining Nephritic Factors as Diverse Drivers of Systemic Complement Dysregulation in C3 Glomerulopathy.将肾炎因子定义为C3肾小球病中系统性补体失调的多种驱动因素。
Kidney Int Rep. 2023 Nov 30;9(2):464-477. doi: 10.1016/j.ekir.2023.11.025. eCollection 2024 Feb.
4
A Monoclonal Antibody That Provides a Model for C3 Nephritic Factors.一种提供 C3 肾炎因子模型的单克隆抗体。
Monoclon Antib Immunodiagn Immunother. 2023 Feb;42(1):9-14. doi: 10.1089/mab.2022.0028.
5
Modeling C3 glomerulopathies: C3 convertase regulation on an extracellular matrix surface.建模 C3 肾小球疾病:细胞外基质表面上的 C3 转化酶调节。
Front Immunol. 2023 Jan 18;13:1073802. doi: 10.3389/fimmu.2022.1073802. eCollection 2022.
6
Challenges in diagnostic testing of nephritic factors.肾病因子诊断检测的挑战。
Front Immunol. 2022 Nov 14;13:1036136. doi: 10.3389/fimmu.2022.1036136. eCollection 2022.
7
Physiology and pathology of the C3 amplification cycle: A retrospective.C3 扩增循环的生理学和病理学:回顾。
Immunol Rev. 2023 Jan;313(1):217-224. doi: 10.1111/imr.13165. Epub 2022 Nov 21.
8
Test for Measuring Complement Attack on Endothelial Cells: From Research to Bedside.检测补体攻击血管内皮细胞的方法:从研究到临床。
Front Immunol. 2022 Apr 12;13:860689. doi: 10.3389/fimmu.2022.860689. eCollection 2022.
9
A clinical approach to children with C3 glomerulopathy.儿童C3肾小球病的临床诊疗方法
Pediatr Nephrol. 2022 Mar;37(3):521-535. doi: 10.1007/s00467-021-05088-7. Epub 2021 May 18.
10
Detection of C3 Nephritic Factor by Hemolytic Assay.溶血检测法检测 C3 肾炎因子。
Methods Mol Biol. 2021;2227:147-158. doi: 10.1007/978-1-0716-1016-9_15.